✨ Free AI Report
Novanta Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Novanta Inc.
Company Research

Novanta Inc.: Business Overview, Financials & Competitive Analysis

Novanta Inc. scores 7/10 on the AskCyborg Cyborg Score (Strong). Novanta's proprietary precision technology and emerging robotics exposure position it well for long-term growth, despite current macroeconomic pressures requiring operational optimization. Q3 2025 showed bookings growth of 17% YoY with book-to-bill of 1.03x and adjusted EBITDA of $58.1M. The company reiterated product-driven growth and provided 2026 mid-single-digit organic growth expectations.

What is Novanta Inc.'s industry? Novanta Inc. (novanta.com) operates in Precision Manufacturing & Photonics / Medical Devices / Industrial Automation. AskCyborg classifies Novanta Inc. under Precision Manufacturing & Photonics / Medical Devices / Industrial Automation in its company registry.

Novanta manufactures photonic and motion-control components for medical equipment and industrial technology markets, operating in two segments: Automation Enabling Technologies and Medical Solutions. The company is a ...

7/ 10Strong

Cyborg Score thesis

Novanta's proprietary precision technology and emerging robotics exposure position it well for long-term growth, despite current...

Read the full analyst-debate transcript →
Industry Precision Manufacturing & Photonics / Medical Devices / Industrial Automation
4 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest Novanta Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Novanta Inc.

AskCyborg analysts argue the bull and bear cases for Novanta Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Novanta Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Novanta Inc. Overview

Pro stress-test →

Novanta manufactures photonic and motion-control components for medical equipment and industrial technology markets, operating in two segments: Automation Enabling Technologies and Medical Solutions. The company is a leading supplier of core technology solutions combining deep proprietary expertise in precision medicine and manufacturing, medical solutions, and robotics and automation to engineer core components and sub-systems that deliver extreme precision and performance.

Strategic Profile

Pro stress-test →

Novanta signed a major $50 million warehouse robotics contract with a leading e-commerce company, with revenue commencing in 2026. The company is collaborating with over 10 leading humanoid robotics players across North America and Europe on multiple projects with significant content.

Competitive Landscape

Pro stress-test →

The Medical Solutions segment generates majority revenue from medical insufflators, pumps, visualization solutions, and wireless technologies. Novanta competes with larger diversified industrial suppliers and specialized precision component manufacturers. Key competitors include Teledyne Technologies, II-VI Incorporated (now Coherent), and various laser/motion control specialists.

Industry Context

Novanta Inc. operates in Precision Manufacturing & Photonics / Medical Devices / Industrial Automation.

Key facts

Founded: 1968 · Headquarters: Bedford, Massachusetts · Revenue: $960M · Market cap: $5.19B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Novanta Inc..

  • Key 2026 organic growth drivers include the continued ramp of advanced surgery products, rapid deployment of robotics in warehouse automation driven by physical AI applications, and impact of new design wins across various sectors.
  • NIH funding cuts and broader hesitancy in life science capital spending impacted the precision medicine segment, with China delisting of a customer contributing to a weaker environment.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Q4 2025 earnings release scheduled for February 24, 2026
  • January 2026CEO and CFO presenting at J.P. Morgan 44th Annual Healthcare Conference
  • +2 moreTrack every material event for Novanta Inc. as it happens. Explore monitoring →
Get alerted when Novanta Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Novanta Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Novanta Inc. operates in Precision Manufacturing & Photonics / Medical Devices / Industrial Automation. See how the rest of the sector scores on the Cyborg framework.

Browse Precision Manufacturing & Photonics / Medical Devices / Industrial Automation research →
NEW · MCP server

Ask your AI assistant about Novanta Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Novanta Inc. and its top competitor on Cyborg Score”
“What did Novanta Inc. do this quarter?”
“Is Novanta Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Novanta Inc. do?+
Novanta manufactures photonic and motion-control components for medical equipment and industrial technology markets, operating in two segments: Automation Enabling Technologies and Medical Solutions. The company is a ...
What is Novanta Inc.'s Cyborg Score?+
Novanta Inc. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Novanta Inc.'s main competitors?+
Named competitors include Coherent, Teledyne Technologies, Brooks Automation, MicroVision. The full competitive landscape is in the AskCyborg report.
How can I get the full Novanta Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Novanta Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Novanta Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual